Found 187 matching trials
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
PHASE3Comparative trial of tolerability, reactogenicity, safety and immunogenicit...
Location
LLC "Energiya zdorov'ya"
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children
PHASE2Primary Objective:
To evaluate for each influenza strain the non-inferiori...
Location
Multiple Locations
Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine
PHASE1The study is a single centre, phase I, double-blind, randomized, placebo-co...
Location
Kazakh National Medical University
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
PHASE2Influenza virus is a significant pathogen in pediatric solid organ transpla...
Location
Stanford University
Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)
PHASE2This study is in support of the annual application for the variation of the...
Location
Multiple Locations
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
PHASE3The primary purpose of this study is to demonstrate the efficacy of an inve...
Location
Multiple Locations
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
PHASE2Lung allograft recipients have a higher burden of influenza disease and gre...
Location
Vanderbilt University Medical Center
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea
PHASE4This study is designed to assess the immunogenicity and safety of the 2010-...
Location
Multiple Locations
Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24
N/AThis EPSS will determine the vaccinee reporting rates (RRs) of suspected AD...
Location
Investigational Site Number : 2460001
Tolerability, Safety and Immunogenicity Trial of the Flu-M® Inactivated Vaccine in Volunteers Aged 18 to 60 Years
PHASE3Comparative assessment of the tolerability, safety, and immunogenicity of t...
Location
State Autonomous Health Institution "Engels City Clinical Hospital No1"